Efficacy of Diterpene Ginkgolides Meglumine Injection in Elderly Patients With Ischemic Stroke
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
A randomized positived-controlled study of Diterpene Ginkgolides Meglumine Injection (DGMI)
vs Ginaton in patients with ischemic stroke (IS) was conducted between7/2013 and 4/2014. The
study was designed to test efficacy of DGMI for IS. Post hoc analysis of this trial was
conducted to evaluate the efficacy of DGMI in elderly (agedā„65 years) IS patients.